Evidence map›Paper›PMID 40778945›Full record

ArticleWorld journal of urology2025

Contemporary rates and predictors of prolonged hospital stay after radical cystectomy: a population-based analysis.

Natali Rodriguez Peñaranda, Fabian Falkenbach, Andrea Marmiroli, Mattia Longoni, Quynh Chi Le, Calogero Catanzaro, Michele Nicolazzini, Francesco Di Bello, Jordan A Goyal, Fred Saad and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Natali Rodriguez PeñarandaCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada. natalirodriguez647@gmail.com.ORCID http://orcid.org/0009-0006-3057-3805
Fabian FalkenbachCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Andrea MarmiroliCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Mattia LongoniCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Quynh Chi LeCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Calogero CatanzaroCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Michele NicolazziniCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Francesco Di BelloCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Jordan A GoyalCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Fred SaadCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Shahrokh F ShariatDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Gennaro MusiDepartment of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
Markus GraefenMartini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Alberto BrigantiDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Felix K H ChunDepartment of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.
Riccardo SchiavinaDepartment of Urology, University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy.
Alessandro VolpeDivision of Urology, Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.
Stefano RescaDepartment of Urology, AOU di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini, 1355, 41126, Baggiovara, Italy.
Ivan Matteo TavoliniIGG Italian Germ Cell Cancer Group, Genova, Italy.
Stefano PuliattiDepartment of Urology, AOU di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini, 1355, 41126, Baggiovara, Italy.
Salvatore MicaliDepartment of Urology, AOU di Modena, University of Modena and Reggio Emilia, Via Pietro Giardini, 1355, 41126, Baggiovara, Italy.
Pierre I KarakiewiczCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo test contemporary rates and predictors of prolonged hospital stay after radical cystectomy (RC) and ileal conduit in non-metastatic bladder cancer patients.

methodsWithin the National Inpatient Sample database (NIS, 2008-2019), we identified ileal conduit RC patients and tabulated length of stay (LOS) ≥ 75th percentile vs. others. Temporal trends and multivariable logistic regression models (LRM) were fitted.

resultsOf 10,934 patients, 3,116 (28%) exhibited LOS ≥ 75th percentile (≥ 10 days), with rates decreasing from 35.4% in 2008 to 20.0% in 2019 (p < 0.001). In multivariable LRM, independent predictors of LOS ≥ 75th percentile were age ≥ 80 years (OR 1.37), CCI ≥ 2 (OR 1.55), coagulopathy (OR 1.55), obesity (OR 1.15), African American race/ethnicity (OR 1.57), female sex (OR 1.17), Medicare (OR 1.24) or Medicaid (OR 1.41) insurance, and treatment at low- (OR 1.68) or medium-volume hospitals (OR 1.33). Conversely, minimally invasive surgery (OR 0.59) exhibited the opposite protective effect (all p ≤ 0.03). Interestingly, the combined effect of age (≥ 80 vs. < 80 years) and surgical approach (minimally invasive vs. open) also achieved independent predictive status. Specifically, patients aged ≥ 80 undergoing minimally invasive, < 80 undergoing open, and ≥ 80 undergoing open surgery were, respectively, 1.35, 1.65, and 2.29 times more likely to require LOS ≥ 75th percentile compared to those aged < 80 undergoing minimally invasive surgery (all p ≤ 0.004).

conclusionThe proportion requiring LOS ≥ 75th percentile decreased over time. Multivariable LRMs showed that age, race, insurance, hospital characteristics, and surgical approach were significantly associated with LOS ≥ 75th percentile. Combinations of variables, such as age ≥ 80 and open surgery, identified higher-risk subgroups.

Indexed as

CystectomyLength of StayUrinary Bladder NeoplasmsUrinary DiversionAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesUnited StatesAgeCystectomyIleal conduitLOSMinimally invasive surgeryPredictors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.